We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04597632
Brief Title: An Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) Study (TALON Ext)

First Submitted : October 1, 2020
First Submitted that Met QC Criteria : October 15, 2020
First Posted : October 22, 2020

Last Update Submitted that Met QC Criteria : January 20, 2023
Last Update Posted : January 23, 2023